Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin vs Misoprostol for Blood Loss in Elective C-Section
NCT01412073Phase 3Completed
- Sponsor
- Cairo University
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin and misoprostol in postpartum hemorrhage (PPH), sponsored by Cairo University. Primary endpoint: Amount of operative blood loss. Started Sep 2011; status: completed.
02
Drugs
oxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01412073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412073.